{"verbs": [{"verb": "gives", "description": "[ARG0: israel] [ARGM-DIS: teva] [V: gives] [ARG1: upbeat outlook] [ARGM-ADV: as restructuring proceeds israeli drug maker teva pharmaceutical industries] [ARGM-TMP: on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories] but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["B-ARG0", "B-ARGM-DIS", "B-V", "B-ARG1", "I-ARG1", "B-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "B-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "reported", "description": "israel teva gives upbeat outlook as restructuring proceeds [ARG0: israeli drug maker teva pharmaceutical industries] [ARGM-TMP: on thursday] [V: reported] [ARG1: a third - quarter loss] [ARGM-TMP: as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories] but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "B-ARG0", "I-ARG0", "I-ARG0", "I-ARG0", "I-ARG0", "I-ARG0", "B-ARGM-TMP", "I-ARGM-TMP", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "B-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "I-ARGM-TMP", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "proceeds", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as [ARG0: it] [V: proceeds] [ARG1: with an aggressive cost - cutting program] and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG0", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "cutting", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive [ARG1: cost] - [V: cutting] [ARG0: program] and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG1", "O", "B-V", "B-ARG0", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "gave", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but [ARG0: the company] [V: gave] [ARG1: an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares] surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG0", "I-ARG0", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "citing", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave [ARG0: an upbeat outlook] [V: citing] [ARG1: stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares] surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG0", "I-ARG0", "I-ARG0", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "progress", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and [V: progress] [ARG1: with its restructuring program teva shares] surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "restructuring", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its [V: restructuring] program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "surged", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program [ARG1: teva shares] [V: surged] [ARGM-LOC: on the news] teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG1", "I-ARG1", "B-V", "B-ARGM-LOC", "I-ARGM-LOC", "I-ARGM-LOC", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "posted", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news [ARG0: teva] [V: posted] [ARG1: a loss of 273 million or 27 cents a share] [ARGM-ADV: compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel]", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG0", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "B-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV", "I-ARGM-ADV"]}, {"verb": "compared", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted [ARG1: a loss of 273 million or 27 cents a share] [V: compared] [ARG2: with earnings of 530 million or 52 cents a share the previous year revenue] fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "B-V", "B-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "I-ARG2", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "fell", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with [ARG1: earnings of 530 million or 52 cents a share the previous year revenue] [V: fell] [ARG2: 19 percent] [ARG3: from 5 617 billion to 4 529 billion teva kare schultz teva learning center teva pharmaceutical industries israel]", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "B-V", "B-ARG2", "I-ARG2", "B-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3", "I-ARG3"]}, {"verb": "kare", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva [V: kare] schultz teva learning center teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "learning", "description": "israel teva gives upbeat outlook as restructuring proceeds israeli drug maker teva pharmaceutical industries on thursday reported a third - quarter loss as it proceeds with an aggressive cost - cutting program and adjusts to declines in key product categories but the company gave an upbeat outlook citing stabilization in its core generics business the launch of new products and progress with its restructuring program teva shares surged on the news teva posted a loss of 273 million or 27 cents a share compared with earnings of 530 million or 52 cents a share the previous year revenue fell 19 percent from 5 617 billion to 4 529 billion teva kare schultz teva [V: learning] [ARG0: center] teva pharmaceutical industries israel", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "B-ARG0", "O", "O", "O", "O"]}], "words": ["israel", "teva", "gives", "upbeat", "outlook", "as", "restructuring", "proceeds", "israeli", "drug", "maker", "teva", "pharmaceutical", "industries", "on", "thursday", "reported", "a", "third", "-", "quarter", "loss", "as", "it", "proceeds", "with", "an", "aggressive", "cost", "-", "cutting", "program", "and", "adjusts", "to", "declines", "in", "key", "product", "categories", "but", "the", "company", "gave", "an", "upbeat", "outlook", "citing", "stabilization", "in", "its", "core", "generics", "business", "the", "launch", "of", "new", "products", "and", "progress", "with", "its", "restructuring", "program", "teva", "shares", "surged", "on", "the", "news", "teva", "posted", "a", "loss", "of", "273", "million", "or", "27", "cents", "a", "share", "compared", "with", "earnings", "of", "530", "million", "or", "52", "cents", "a", "share", "the", "previous", "year", "revenue", "fell", "19", "percent", "from", "5", "617", "billion", "to", "4", "529", "billion", "teva", "kare", "schultz", "teva", "learning", "center", "teva", "pharmaceutical", "industries", "israel"]}